These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3172370)

  • 1. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
    Girdley FM; Bruskewitz RC; Feyzi J; Graversen PH; Gasser TC
    J Urol; 1988 Nov; 140(5):972-4. PubMed ID: 3172370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA; Cameron JS; Duffy LM; Lange PH
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.
    Levine SB; Althof SE; Turner LA; Risen CB; Bodner DR; Kursh ED; Resnick MI
    J Urol; 1989 Jan; 141(1):54-7. PubMed ID: 2908954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
    Gasser TC; Roach RM; Larsen EH; Madsen PO; Bruskewitz RC
    J Urol; 1987 Apr; 137(4):678-80. PubMed ID: 3550149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impotence: treatment by autoinjection of vasoactive drugs.
    Williams G; Mulcahy MJ; Kiely EA
    Br Med J (Clin Res Ed); 1987 Sep; 295(6598):595-6. PubMed ID: 3117249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
    Zorgniotti AW; Lefleur RS
    J Urol; 1985 Jan; 133(1):39-41. PubMed ID: 2578067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of vasoactive drugs in male sexual impotence].
    Morales JC; Elizondo B
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
    Hu KN; Burks C; Christy WC
    J Urol; 1987 Aug; 138(2):404-5. PubMed ID: 2439714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
    Bodner DR; Lindan R; Leffler E; Kursh ED; Resnick MI
    J Urol; 1987 Aug; 138(2):310-1. PubMed ID: 3599245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intracavernous pharmacotherapy for organic impotence in the elderly].
    Richter S; Shalev M; Nissenkorn I
    Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with triple-drug therapy in a pharmacological erection program.
    Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
    J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
    Stief CG; Wetterauer U; Kulvelis F; Popken G; Staubesand J; Sommerkamp H
    Urol Int; 1990; 45(6):321-5. PubMed ID: 2288047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.